DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 -3.91 -0.08%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

CLOVIS ONCOLOGY INC (NASDAQ: CLVS)

82.94 -2.94 (-3.42%)

Quote as of

Extended Hours: $83.10 $0.16 (0.19%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

CLVS $82.94 -3.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $85.93
Previous Close $85.88
Daily Range $82.22 - $85.93
52-Week Range $35.33 - $102.28
Market Cap $2.8B
P/E Ratio -15.15
Dividend (Yield) $0.00 (0.0%)
Volume 522,851
Average Daily Volume 637,768
Current FY EPS -$8.39

Sector

Industry

CLOVIS ONCOLOGY INC (CLVS) Description

Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring developing and commercializing innovative anti-cancer agents in the United States Europe and additional international markets. Website: http://www.clovisoncology.com/

News & Commentary

Why Clovis Oncology, Inc. Is Soaring Higher Today

A key Wall Street upgrade sent shares in Clovis Oncology, Inc. higher today.

Clovis Oncology Starts Rolling NDA Submission for Rociletinib - Analyst Blog

Fly Watch: Biotech Sector Events To Watch For This Summer

Clovis Oncology Initiates Rolling NDA Submission to the FDA for Rociletinib in the Treatment of Adva

Clovis Oncology Initiates Rolling NDA Submission to the FDA for Rociletinib in the Treatment of Advanced EGFR-Mutant Non-small Cell Lung Cancer

Clovis Oncology Is A Buy Despite Mixed Data

ImmunoGen Surges on Positive Ovarian Cancer Study Data - Analyst Blog

Morning Market Losers

Benzinga's Top #PreMarket Losers

ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab

Clovis Wins One ASCO '15 Battle, Loses Another, Against Rival AstraZeneca

Fly Watch: Several Names That May Move Following ASCO Meeting

See More CLVS News...